XLO (Xilio Therapeutics, Inc. Common Stock) Stock Analysis - SEC Filings

Xilio Therapeutics, Inc. Common Stock (XLO) is a publicly traded Healthcare sector company. As of May 21, 2026, XLO trades at $8.44 with a market cap of $48.76M and a P/E ratio of -1.97. XLO moved +1.83% today. Year to date, XLO is -10.87%; over the trailing twelve months it is -32.88%. Its 52-week range spans $6.47 to $23.80. Rallies surfaces XLO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find XLO SEC filings?

Rallies organizes XLO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

XLO Key Metrics

Key financial metrics for XLO
MetricValue
Price$8.44
Market Cap$48.76M
P/E Ratio-1.97
EPS$-4.19
Dividend Yield0.00%
52-Week High$23.80
52-Week Low$6.47
Volume0
Avg Volume0
Revenue (TTM)$43.77M
Net Income$-35.04M
Gross Margin0.00%

Latest XLO News

Recent XLO Insider Trades

  • Shannon James Samuel bought 5.00K (~$43.95K) on Mar 26, 2026.
  • Brennan Kevin M. sold 1.83K (~$1.17K) on Jan 2, 2026.
  • Frankenfield Christopher James sold 7.03K (~$4.52K) on Jan 2, 2026.

XLO Analyst Consensus

XLO analyst coverage data. Average price target: $0.00.

Common questions about XLO

Where can I find XLO SEC filings?
Rallies organizes XLO SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show XLO 10-K and 10-Q filings?
Rallies organizes XLO SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is XLO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XLO. It does not provide personalized investment advice.
XLO

XLO